Insulin-Like Growth Factor I Produces an Antidepressant-Like Effect and Elicits N-Methyl-D-Aspartate Receptor Independent Long-Term Potentiation of Synaptic Transmission in Medial Prefrontal Cortex and Hippocampus
Author(s) -
Jeffrey Burgdorf,
Xiao-lei Zhang,
Elizabeth M. Colechio,
Nayereh GhoreishiHaack,
Amanda L. Gross,
Roger A. Kroes,
Patric K. Stanton,
Joseph R. Moskal
Publication year - 2015
Publication title -
the international journal of neuropsychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 107
eISSN - 1469-5111
pISSN - 1461-1457
DOI - 10.1093/ijnp/pyv101
Subject(s) - long term potentiation , neuroscience , prefrontal cortex , antidepressant , hippocampus , ampa receptor , long term depression , hippocampal formation , psychology , nmda receptor , medicine , receptor , cognition
Growth factors play an important role in regulating neurogenesis and synapse formation and may be involved in regulating the antidepressant response to conventional antidepressants. To date, Insulin-like growth factor I (IGFI) is the only growth factor that has shown antidepressant properties in human clinical trials. However, its mechanism of action remains unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom